Insulin resistance treatment works in a repeatable order. You measure it properly first, because most people who carry it have never seen the numbers that reveal it. You change what is on the plate and how your muscle behaves next, because those two levers carry most of the early result. Medication joins when the numbers say it should. The part almost nobody offers is the sequence wrapped in monitoring, which decides whether the result holds for a decade or fades with the first stressful quarter.
This guide walks through that order in full. It explains which labs expose the problem, which levers do the early work, where medication earns its place and how we monitor all of it inside the membership.
- Insulin resistance is measurable with fasting insulin, HOMA-IR, HbA1c and the triglyceride to HDL ratio rather than a single glucose value.
- Two levers carry most of the early result, which are what you eat and how much your muscle works.
- Medication including metformin and branded GLP-1 therapy has real trial support once lifestyle alone stops moving the numbers.
- Improvement shows up in repeat labs within weeks to months, which is why the monitoring is part of the treatment rather than an afterthought.
- Our flat $299 membership covers the clinician and the quarterly labs, so nobody here earns more from a refill than from a result.
The problem nobody named
Here is the pattern we meet most weeks. Someone in their forties or fifties has gained weight around the middle, feels tired after meals and has watched their triglycerides creep up while their HDL slid down. Their doctor ran a basic metabolic panel, called the glucose normal and moved on. Nobody ordered a fasting insulin. Nobody connected the waist, the fatigue and the lipid pattern into the one story they tell together.
That story is insulin resistance. It is the stage where your cells respond sluggishly to insulin, so your pancreas compensates by making more of it. The glucose stays normal for years because the insulin is doing double duty. Meanwhile the extra insulin drives fat storage around the liver and the waistline, raises triglycerides and quietly works your pancreas harder than it was built to run. By the time fasting glucose or A1c crosses into the abnormal range, the compensation has often been running for a decade. The NIDDK describes this progression plainly, from insulin resistance through prediabetes toward Type 2 diabetes and the leverage is almost entirely in the early stage.
What it feels like from the inside
From the inside the stage has a texture. Energy dips hardest after lunch. The scale moves despite meals that never changed. Cravings cluster in the evening. Bloodwork drifts a little worse each year and each year gets called borderline. We treat that texture as data, because patients reliably feel insulin resistance years before panels flag it and the entry points we hear most are a rising A1c, weight that will not move and labs a doctor called normal.
If that description sits close to home, the question is not whether you lack discipline. The question is whether anyone has ever run the panel that shows the compensation happening and the answer for most people is no.
The numbers that expose insulin resistance
| Marker | What it shows | Why standard care misses it |
|---|---|---|
| Fasting insulin | How hard your body works to hold glucose down | Rarely ordered unless a patient asks |
| HOMA-IR | Insulin and glucose combined into one resistance score | A calculation most visits never run |
| HbA1c | Average glucose over roughly three months | Stays normal for years while compensation runs |
| Triglyceride to HDL ratio | A cheap window into the metabolic picture | Reported as two numbers, never connected |
| Waist measurement | The visceral fat driving most of the resistance | Takes seconds and gets skipped just as fast |
Why the standard workup misses it
The visits most of our members describe follow a script built for acute problems. Something hurts, something gets tested, something gets treated. Insulin resistance produces none of that. It produces a slow drift in energy, weight and bloodwork that each look almost normal in isolation. A glucose of 96 and an A1c of 5.6 both sit inside the normal range while a fasting insulin of 22 tells the actual story. Reading the panels together is the clinical work and it is the work the fifteen-minute visit was never designed to do.
The order that works
Step one, measure
Treatment that cannot be measured cannot be trusted. The first step in our protocol is a full panel drawn through the Beluga Health lab network, including fasting insulin, HOMA-IR, HbA1c, a full lipid panel with ApoB, hs-CRP and the hormone and thyroid panels, because thyroid function and sex hormones shift the same metabolism the insulin story runs through. We repeat that panel every 90 days as the Biomarker Audit, because a trend carries information a snapshot never will.
Step two, the two levers that carry the early result
Food and muscle are the levers and the order matters less than the honesty. On the food side the practical pattern is fewer fast-absorbing carbohydrates, more protein and fiber and eating windows that leave real gaps between meals. None of it is exotic. All of it is uncomfortable to sustain without support, which is why the monitoring matters as much as the plan itself.
On the muscle side, resistance training two to three times per week is the most underprescribed insulin-sensitizing intervention in medicine. Muscle is the largest sink for post-meal glucose and trained muscle pulls glucose out of the blood with very little insulin. We set out the training pattern in how strength training changes GLP-1 weight loss results and the same logic applies before any medication enters the picture.
The Diabetes Prevention Program remains the reference point here. A structured program of modest weight loss and activity cut the progression to Type 2 diabetes by 58 percent, which beat metformin in the same trial. The results are real and so is the difficulty, because the program demanded sustained behavior in a system that offers almost no support for it.
Step three, medication when the numbers say so
Medication is not a failure of the first two steps. It is what the evidence supports when the first two steps have been honest and the numbers have not moved enough. Metformin has decades of safety data and reduced progression in the same prevention trial, at a smaller effect than the lifestyle arm. For patients whose picture includes significant weight to lose, branded GLP-1 therapy changes the equation more than anything else on the list, both through weight and through direct effects on insulin signaling. The registration trials showed average reductions around fifteen percent of body weight for semaglutide and up to about twenty-two percent for tirzepatide, with individual results varying widely and glycemic markers improve alongside the weight.
What we prescribe is branded and FDA-approved only, including Wegovy, Zepbound, Ozempic, Mounjaro, Wegovy Tablets and Foundayo. Compounded GLP-1 is never prescribed under any circumstance and we explain why for anyone weighing the cheaper copy. What we do not do is prescribe into a vacuum. A GLP-1 for insulin resistance with no protein plan and no resistance training produces a smaller body with the same problem inside it.
What the monitoring adds and when you see it
Insulin physiology responds faster than most patients expect. Fasting insulin and triglycerides often move within six to twelve weeks of real change. HbA1c lags by design, since it averages three months of glucose, which is why we read it at the 90-day mark rather than the three-week mark. ApoB and hs-CRP fill in the cardiovascular frame, because insulin resistance and atherosclerotic risk travel together and treating one while ignoring the other is half a plan.
A good result is not a smaller number on the scale alone. It is a fasting insulin that falls toward the middle of its range, a triglyceride to HDL ratio that normalizes, a waist that shrinks and a strength number in the gym that holds or rises while all of that happens.
The objection we hear most, answered
The fair objection goes like this. My doctor says my glucose is fine and my insurance covered a diet class, so why would I pay $299 a month for a membership? Our honest answer is that the glucose was never the whole test. A basic panel can read normal for a decade while the compensation runs and a diet class without labs, medication options or follow-up asks you to do the hardest part of medicine alone. The membership exists so that the measuring, the adjusting and the accountability sit with a clinician rather than with your willpower.
Here is the math of the offer, stated the way we state it everywhere. The Cardiometabolic Optimization Membership is one flat $299 per month. The first charge is $598 at checkout, which covers the first two months together, including your clinical intake, your first comprehensive Biomarker Audit and the clinical care while your protocol is built. From month three it is $299 per month, month to month and you can cancel anytime after the initial commitment. The fee covers the doctor and the labs. Medication is a separate charge, billed by your pharmacy at pharmacy cost, with zero markup, no molecule upcharge and no dose-escalation fee. One flat fee for the doctor. Zero markup on the medicine. We make money when you get healthier, not when your dose gets stronger.
Clinical care is delivered by licensed physicians of Beluga Health, P.A., an independent Florida professional corporation licensed to practice in all 50 states, working under GoodLife Health's clinical protocols. Additional labs beyond the quarterly cadence are billed to you at pass-through cost and we tell you before they are ordered.
What to do this month
Three moves put you ahead of most patients with this picture. Ask for a fasting insulin at your next draw, because it is the number the standard panel leaves out. Put resistance training on the calendar twice before the month ends, because the muscle is the intervention nobody bills you for. If your panel shows the pattern this guide describes, take it to a clinician who will name the stage and set the thresholds rather than call it borderline. Check your eligibility or read what Cardiometabolic Optimization means to see whether the model fits you.
FAQ
What is insulin resistance in simple terms? Your cells respond to insulin more weakly than they should, so your body compensates by making extra insulin to hold blood sugar in the normal range. The glucose looks fine for years while the extra insulin drives weight gain around the middle and rising triglycerides. Measuring the insulin itself is how you catch the stage early.
How is insulin resistance diagnosed? Through a pattern rather than a single flag. Fasting insulin, HOMA-IR, HbA1c, the triglyceride to HDL ratio and a waist measurement read together tell the story. A normal fasting glucose rules out very little, because the compensation keeps it normal until late.
Can insulin resistance be reversed? In many people, yes. The Diabetes Prevention Program showed a 58 percent reduction in progression to Type 2 diabetes with modest weight loss and activity and patients who add effective weight-loss medication often see insulin and triglyceride markers fall within months. Reversal means holding the result, which is why monitoring continues after the numbers improve.
What diet is best for insulin resistance? The one you can hold. The practical pattern emphasizes protein, fiber and fewer fast-absorbing carbohydrates with real gaps between meals. We set individual targets in the protocol rather than handing over a template, because kidney function, medication and training all change the right answer.
Do I need medication for insulin resistance? Medication is not automatic. Metformin and branded GLP-1 therapy earn their place when lifestyle has been honest and the numbers have not moved enough. The decision belongs to a clinician reading your panels, which is precisely what the quarterly Biomarker Audit exists for.
How much does treatment cost at GoodLife Health? The membership is a flat $299 per month after a $598 first charge that covers the first two months together, including the clinician and the quarterly Biomarker Audit. Medication is billed separately by your pharmacy at cost with zero markup from us.
Is this different from my annual physical? An annual physical screens for disease that has already crossed a threshold. Our model measures the compensation before the threshold and treats it while reversal is still the easy version. The cadence is quarterly, the panels are broader and the same clinician reads your trend each time.
Related Reading
- How to reverse insulin resistance with medical support
- Best labs to request at a metabolic health checkup
- Cardiometabolic optimization: the definitive guide
- Direct primary care at GoodLife Health
References
- NIDDK: Insulin Resistance and Prediabetes. 2023. www.niddk.nih.gov/health-information/diabetes/insulin-resistance-prediabetes
- Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin (Diabetes Prevention Program, New England Journal of Medicine). 2002. www.nejm.org/doi/full/10.1056/NEJMoa012512